|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000101166 |
Summary for SLMO2 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000101166 | Gene symbol | SLMO2 |
| Gene name | PRELI domain containing 3B | |
| HGNC | 15892 | |
| Entrez ID | 51012 | |
| Gene type | protein_coding | |
| Synonyms | PRELID3B|dJ543J19.5 | |
| UniProtAcc | Q9Y3B1 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for SLMO2 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for SLMO2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for SLMO2 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg08363339 | chr20:59043432 | CGI:chr20:59042375-59043167 | promoter | 6.75e-01 | 8.29e-01 | -2.47e+00 | 1.34e-02 | 2.99e-02 | -1.54e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg26216876 | chr20:59042028 | CGI:chr20:59042375-59043167 | promoter,gene body | 4.68e-01 | 6.05e-01 | -2.83e+00 | 4.71e-03 | 6.12e-03 | -1.37e-01 |
| KIRC | cg02902946 | chr20:59042113 | CGI:chr20:59042375-59043167 | promoter,gene body | 6.07e-01 | 7.68e-01 | -3.66e+00 | 2.56e-04 | 4.67e-04 | -1.61e-01 |
| LUSC | cg08363339 | chr20:59043432 | CGI:chr20:59042375-59043167 | promoter | 4.94e-01 | 8.32e-01 | -4.33e+00 | 1.47e-05 | 5.26e-04 | -3.38e-01 |
| LUSC | cg18912847 | chr20:59041842 | CGI:chr20:59042375-59043167 | promoter,gene body | 5.91e-01 | 8.57e-01 | -4.12e+00 | 3.84e-05 | 5.32e-04 | -2.67e-01 |
| LUSC | cg26216876 | chr20:59042028 | CGI:chr20:59042375-59043167 | promoter,gene body | 2.45e-01 | 3.60e-01 | -2.75e+00 | 5.95e-03 | 9.30e-03 | -1.15e-01 |
| LUSC | cg02902946 | chr20:59042113 | CGI:chr20:59042375-59043167 | promoter,gene body | 4.04e-01 | 6.87e-01 | -3.99e+00 | 6.49e-05 | 5.96e-04 | -2.83e-01 |
| COAD | cg20726575 | chr20:59041136 | CGI:chr20:59042375-59043167 | promoter,gene body | 3.37e-01 | 4.60e-01 | -3.04e+00 | 2.35e-03 | 4.50e-03 | -1.23e-01 |
| COAD | cg02902946 | chr20:59042113 | CGI:chr20:59042375-59043167 | promoter,gene body | 1.91e-01 | 3.09e-01 | -3.69e+00 | 2.26e-04 | 6.73e-04 | -1.18e-01 |
| LIHC | cg02902946 | chr20:59042113 | CGI:chr20:59042375-59043167 | promoter,gene body | 2.49e-01 | 3.83e-01 | -5.69e+00 | 1.27e-08 | 9.64e-08 | -1.34e-01 |
| CHOL | cg18912847 | chr20:59041842 | CGI:chr20:59042375-59043167 | promoter,gene body | 6.51e-01 | 8.47e-01 | -2.21e+00 | 2.70e-02 | 3.50e-02 | -1.96e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg08363339 | chr20:59043432 | CGI:chr20:59042375-59043167 | promoter | 6.75e-01 | 5.67e-01 | 5.34e+00 | 9.17e-08 | 1.88e-07 | 1.09e-01 |
| BRCA | cg18912847 | chr20:59041842 | CGI:chr20:59042375-59043167 | promoter,gene body | 5.99e-01 | 7.80e-01 | -1.05e+01 | 5.69e-26 | 5.31e-25 | -1.81e-01 |
| BRCA | cg02902946 | chr20:59042113 | CGI:chr20:59042375-59043167 | promoter,gene body | 3.19e-01 | 5.22e-01 | -1.22e+01 | 2.46e-34 | 6.49e-33 | -2.03e-01 |
| KIRC | cg08363339 | chr20:59043432 | CGI:chr20:59042375-59043167 | promoter | 8.64e-01 | 7.50e-01 | 3.09e+00 | 2.02e-03 | 6.49e-03 | 1.14e-01 |
Top |
Exon skipping events with PSI in TCGA for SLMO2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BRCA | exon_skip_358364 | 2.22e-01 | 3.34e-01 | -5.02e+00 | 5.13e-07 | 2.43e-06 | -1.11e-01 |
Top |
RNA A-to-I editing events in TCGA for SLMO2 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for SLMO2 |
| TFs related to SLMO2. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | PRDM6 | SLMO2 | 4.08e+00 | 9.89e-01 | 2.74e+00 | 9.83e-04 | Male-biased |
| ACC | ZNF182 | SLMO2 | 4.24e+00 | 9.91e-01 | 2.93e+00 | 1.15e-03 | Male-biased |
| ACC | ZNF22 | SLMO2 | 4.20e+00 | 9.91e-01 | 2.84e+00 | 9.12e-04 | Male-biased |
| ACC | ZNF235 | SLMO2 | 4.23e+00 | 9.92e-01 | 2.81e+00 | 6.99e-04 | Male-biased |
| ACC | ZNF287 | SLMO2 | 4.22e+00 | 9.91e-01 | 2.79e+00 | 6.77e-04 | Male-biased |
| ACC | ZNF384 | SLMO2 | 3.85e+00 | 9.83e-01 | 2.69e+00 | 2.06e-03 | Male-biased |
| ACC | ZNF487 | SLMO2 | 4.13e+00 | 9.90e-01 | 2.81e+00 | 1.09e-03 | Male-biased |
| ACC | ZNF613 | SLMO2 | 4.10e+00 | 9.88e-01 | 2.95e+00 | 2.18e-03 | Male-biased |
| ACC | ZNF98 | SLMO2 | 4.05e+00 | 9.87e-01 | 2.94e+00 | 2.57e-03 | Male-biased |
| BRCA | ZNF573 | SLMO2 | 3.95e+00 | 9.81e-01 | 1.88e+00 | 7.86e-04 | Male-biased |
| GBM | FERD3L | SLMO2 | 2.57e+00 | 3.41e-03 | 4.03e+00 | 9.83e-01 | Female-biased |
| GBM | KLF14 | SLMO2 | 2.34e+00 | 2.24e-03 | 3.96e+00 | 9.82e-01 | Female-biased |
| GBM | KLF3 | SLMO2 | 1.49e+00 | 7.40e-05 | 4.12e+00 | 9.89e-01 | Female-biased |
| GBM | MBD2 | SLMO2 | 1.61e+00 | 3.22e-04 | 3.87e+00 | 9.80e-01 | Female-biased |
| GBM | PHF1 | SLMO2 | 3.41e+00 | 8.21e-03 | 4.54e+00 | 9.86e-01 | Female-biased |
| GBM | TCF7L1 | SLMO2 | 3.49e+00 | 1.10e-02 | 4.51e+00 | 9.83e-01 | Female-biased |
| GBM | ZBTB43 | SLMO2 | 2.75e+00 | 4.19e-03 | 4.13e+00 | 9.84e-01 | Female-biased |
| GBM | ZNF23 | SLMO2 | 1.37e+00 | 1.11e-04 | 3.90e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF235 | SLMO2 | 3.96e+00 | 9.81e-01 | 1.39e+00 | 4.20e-05 | Male-biased |
| GBM | ZNF324B | SLMO2 | 2.27e+00 | 1.86e-03 | 3.95e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF343 | SLMO2 | 2.51e+00 | 2.45e-03 | 4.09e+00 | 9.85e-01 | Female-biased |
| GBM | ZNF431 | SLMO2 | 1.65e+00 | 3.76e-04 | 3.87e+00 | 9.80e-01 | Female-biased |
| GBM | ZNF573 | SLMO2 | 1.85e+00 | 3.91e-04 | 4.06e+00 | 9.87e-01 | Female-biased |
| GBM | ZNF619 | SLMO2 | 1.30e+00 | 8.10e-05 | 3.91e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF682 | SLMO2 | 1.46e+00 | 1.05e-04 | 4.00e+00 | 9.85e-01 | Female-biased |
| GBM | ZNF69 | SLMO2 | 2.25e+00 | 1.58e-03 | 4.00e+00 | 9.84e-01 | Female-biased |
| GBM | ZNF891 | SLMO2 | 1.25e+00 | 6.09e-05 | 3.92e+00 | 9.83e-01 | Female-biased |
| LGG | HMX3 | SLMO2 | 4.33e+00 | 9.80e-01 | 3.85e+00 | 9.34e-03 | Male-biased |
| LGG | PHF1 | SLMO2 | 4.17e+00 | 9.81e-01 | 3.61e+00 | 5.75e-03 | Male-biased |
| LGG | TCF7L1 | SLMO2 | 4.23e+00 | 9.81e-01 | 3.69e+00 | 6.61e-03 | Male-biased |
| LGG | ZNF235 | SLMO2 | 2.14e+00 | 2.32e-05 | 4.01e+00 | 9.82e-01 | Female-biased |
| MESO | DNMT1 | SLMO2 | 2.26e+00 | 1.35e-03 | 4.10e+00 | 9.86e-01 | Female-biased |
| PCPG | PRDM6 | SLMO2 | 2.35e+00 | 2.46e-04 | 3.92e+00 | 9.84e-01 | Female-biased |
| PCPG | ZNF182 | SLMO2 | 2.38e+00 | 4.51e-04 | 3.84e+00 | 9.82e-01 | Female-biased |
| PCPG | ZNF22 | SLMO2 | 2.36e+00 | 3.50e-04 | 3.86e+00 | 9.83e-01 | Female-biased |
| PCPG | ZNF235 | SLMO2 | 2.38e+00 | 1.70e-04 | 4.04e+00 | 9.87e-01 | Female-biased |
| PCPG | ZNF287 | SLMO2 | 2.36e+00 | 2.67e-04 | 3.92e+00 | 9.84e-01 | Female-biased |
| PCPG | ZNF487 | SLMO2 | 2.40e+00 | 5.56e-04 | 3.81e+00 | 9.81e-01 | Female-biased |
| PCPG | ZNF613 | SLMO2 | 2.68e+00 | 1.06e-03 | 3.96e+00 | 9.84e-01 | Female-biased |
| PCPG | ZNF98 | SLMO2 | 2.52e+00 | 6.03e-04 | 3.91e+00 | 9.84e-01 | Female-biased |
| SLMO2 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for SLMO2 |
| RBPs related to ES in SLMO2. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | Fusip1 | exon_skip_358363 | 8.83e+00 | 1.13e-02 | 9.44e+00 | 9.86e-01 | Female-biased |
| SLMO2 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12480501 | chr20:59893921:A:T | - | 0.145003424012215 | 0.0234964227456413 | LIHC | Female-baised eQTL |
| rs17790926 | chr20:59925398:G:T | - | 0.138282976014265 | 0.0445671459631958 | LIHC | Female-baised eQTL |
| rs6021839 | chr20:52288125:T:C | - | -0.145757734402962 | 8.14029171222079e-05 | STAD | Female-baised eQTL |
| rs1043008 | chr20:62387887:T:C | - | 0.138134094557363 | 0.000383681665219715 | STAD | Female-baised eQTL |
| rs8117470 | chr20:56720327:C:A | - | 0.131027486797415 | 0.00132081328048515 | STAD | Female-baised eQTL |
| rs66891574 | chr20:58203844:G:A | - | 0.096884035376968 | 0.00598603042879865 | STAD | Female-baised eQTL |
| rs2143725 | chr20:52296199:A:G | - | -0.100092369776193 | 0.00676332679097259 | STAD | Female-baised eQTL |
| rs2426431 | chr20:52298458:T:C | - | -0.0999049636441096 | 0.00689824973251318 | STAD | Female-baised eQTL |
| rs4811320 | chr20:52298797:A:G | - | -0.0999049636441096 | 0.00689824973251318 | STAD | Female-baised eQTL |
| rs6068127 | chr20:52305086:T:C | - | -0.0999049636441096 | 0.00689824973251318 | STAD | Female-baised eQTL |
| rs2426435 | chr20:52357570:A:G | - | -0.0955020950750671 | 0.010849341564904 | STAD | Female-baised eQTL |
| rs2095232 | chr20:58202935:T:C | - | 0.0883949267743701 | 0.0127767031271356 | STAD | Female-baised eQTL |
| rs6092627 | chr20:58204195:G:A | - | 0.0883949267743701 | 0.0127767031271356 | STAD | Female-baised eQTL |
| rs6013436 | chr20:52322328:G:C | - | -0.0940083613809617 | 0.0142351127321687 | STAD | Female-baised eQTL |
| rs6013437 | chr20:52324622:T:C | - | -0.0940083613809617 | 0.0142351127321687 | STAD | Female-baised eQTL |
| rs6068141 | chr20:52328401:G:A | - | -0.0940083613809617 | 0.0142351127321687 | STAD | Female-baised eQTL |
| rs6021866 | chr20:52336176:A:C | - | -0.0940083613809617 | 0.0142351127321687 | STAD | Female-baised eQTL |
| rs6013442 | chr20:52337121:C:T | - | -0.0940083613809617 | 0.0142351127321687 | STAD | Female-baised eQTL |
| rs6021874 | chr20:52342233:C:T | - | -0.0940083613809617 | 0.0142351127321687 | STAD | Female-baised eQTL |
| rs6127830 | chr20:56735952:G:A | - | 0.10863209964201 | 0.015179840831374 | STAD | Female-baised eQTL |
| rs1923180 | chr20:56734996:G:A | - | 0.108572531550049 | 0.0151992225100233 | STAD | Female-baised eQTL |
| rs35313778 | chr20:56727984:A:C | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs13042931 | chr20:56728187:G:A | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs13042933 | chr20:56728193:G:A | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs13042842 | chr20:56728375:A:G | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs2870765 | chr20:56728713:G:A | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs4499485 | chr20:56728804:C:T | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs2870766 | chr20:56728932:A:G | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs67155471 | chr20:56729056:G:A | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs67348124 | chr20:56729103:T:A | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs6127825 | chr20:56729365:A:G | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs6025110 | chr20:56729388:C:A | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs6123621 | chr20:56729709:T:A | - | 0.10819779807619 | 0.0162124474181648 | STAD | Female-baised eQTL |
| rs2014243 | chr20:52290367:A:G | - | -0.0902442367177887 | 0.0204903105063924 | STAD | Female-baised eQTL |
| rs6123619 | chr20:56722431:C:T | - | 0.0989038989864533 | 0.0411098370760365 | STAD | Female-baised eQTL |
| rs6127823 | chr20:56725569:C:T | - | 0.0989038989864533 | 0.0411098370760365 | STAD | Female-baised eQTL |
| rs563431 | chr20:58200075:T:C | - | -0.0772986795225815 | 0.041402792624766 | STAD | Female-baised eQTL |
| rs6013210 | chr20:51549095:C:G | - | 0.0894723571415725 | 0.0474788329362441 | STAD | Female-baised eQTL |
| rs6068283 | chr20:52621911:C:T | - | -0.0823357314065087 | 0.0476150662926059 | STAD | Female-baised eQTL |
| rs6123622 | chr20:56729734:C:T | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs6123623 | chr20:56730571:A:C | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs8182919 | chr20:56731900:A:G | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs4372969 | chr20:56731985:G:C | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs6127826 | chr20:56732076:T:G | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs34443558 | chr20:56732316:T:A | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs34612703 | chr20:56732359:T:A | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs6127829 | chr20:56732450:A:C | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs35056486 | chr20:56733295:T:C | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs13041946 | chr20:56733819:A:G | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs6123624 | chr20:56733834:T:C | - | 0.0953527301855789 | 0.048351783325614 | STAD | Female-baised eQTL |
| rs73139388 | chr20:60265141:G:A | - | 0.0631790085481335 | 0.0134596622220947 | LUAD | Female-baised eQTL |
| rs10485467 | chr20:60259393:G:A | - | 0.0587410464434139 | 0.0289086242630587 | LUAD | Female-baised eQTL |
| rs73139311 | chr20:60226454:G:C | - | 0.0626444169716089 | 0.03428590466033 | LUAD | Female-baised eQTL |
| rs6092902 | chr20:60222769:A:G | - | 0.0624068551163305 | 0.0343357486867383 | LUAD | Female-baised eQTL |
| rs8125782 | chr20:60263163:G:C | - | 0.0567833963351068 | 0.0378192779346455 | LUAD | Female-baised eQTL |
| rs62205478 | chr20:60295725:C:G | - | 0.062292570556315 | 0.0403497235597892 | LUAD | Female-baised eQTL |
| rs77682249 | chr20:50725096:C:G | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs114099561 | chr20:50725097:T:G | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs78110641 | chr20:50725382:C:T | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs75264611 | chr20:50725476:G:T | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs74907545 | chr20:50725511:C:A | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs78615566 | chr20:50725894:A:G | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs144358881 | chr20:50726271:A:C | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs79169983 | chr20:50727412:C:T | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs75788708 | chr20:50727511:T:G | - | 0.0675208434151252 | 0.0439654039327078 | LUAD | Female-baised eQTL |
| rs112591465 | chr20:50726333:A:C | - | 0.0669492412783186 | 0.0483508191678891 | LUAD | Female-baised eQTL |
| rs114163036 | chr20:60234787:C:T | - | 0.0587035372315286 | 0.0496462330490548 | LUAD | Female-baised eQTL |
| rs4811560 | chr20:54968286:G:A | - | 0.102915069743945 | 0.0334503521643807 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs58143732 | chr20:54460707:C:T | - | 0.0928159513142461 | 0.000609833058574962 | STAD | Male-baised eQTL |
| rs60780716 | chr20:54460980:T:C | - | 0.0885939571397161 | 0.00200852182204977 | STAD | Male-baised eQTL |
| rs73141258 | chr20:54457205:C:T | - | 0.0900948547768023 | 0.00279013371776627 | STAD | Male-baised eQTL |
| rs55957910 | chr20:54462420:T:C | - | 0.0860898901334395 | 0.00471198178983844 | STAD | Male-baised eQTL |
| rs55745150 | chr20:54489701:C:T | - | 0.0971082444074247 | 0.00923017499541482 | STAD | Male-baised eQTL |
| rs7264143 | chr20:54446648:G:A | - | 0.0828106137701498 | 0.00990634992159382 | STAD | Male-baised eQTL |
| rs6097988 | chr20:54448885:C:T | - | 0.0828106137701498 | 0.00990634992159382 | STAD | Male-baised eQTL |
| rs6023253 | chr20:54448349:T:G | - | 0.0754023010727049 | 0.0121525013020651 | STAD | Male-baised eQTL |
| rs6097987 | chr20:54448683:A:G | - | 0.0754023010727049 | 0.0121525013020651 | STAD | Male-baised eQTL |
| rs6091939 | chr20:54630882:C:T | - | 0.0959085696202073 | 0.0128654679364537 | STAD | Male-baised eQTL |
| rs6098129 | chr20:54632311:C:T | - | 0.0959085696202073 | 0.0128654679364537 | STAD | Male-baised eQTL |
| rs73141254 | chr20:54453984:C:A | - | 0.0846146765680678 | 0.0135635128068453 | STAD | Male-baised eQTL |
| rs6097998 | chr20:54466604:G:A | - | 0.0687905243842441 | 0.016804427873358 | STAD | Male-baised eQTL |
| rs6023251 | chr20:54446402:T:C | - | 0.0711322853871055 | 0.017912499681339 | STAD | Male-baised eQTL |
| rs7264053 | chr20:54446723:A:G | - | 0.0711322853871055 | 0.017912499681339 | STAD | Male-baised eQTL |
| rs16999643 | chr20:54450270:T:A | - | 0.0711322853871055 | 0.017912499681339 | STAD | Male-baised eQTL |
| rs56181676 | chr20:54440348:C:T | - | 0.0769382793396212 | 0.0189002175411538 | STAD | Male-baised eQTL |
| rs6023240 | chr20:54435419:G:T | - | 0.0751019972689882 | 0.0213907581591824 | STAD | Male-baised eQTL |
| rs6014032 | chr20:54489814:T:C | - | 0.063458903342594 | 0.0221098803578228 | STAD | Male-baised eQTL |
| rs6023254 | chr20:54450655:T:G | - | 0.0723060706309927 | 0.022641977044124 | STAD | Male-baised eQTL |
| rs6097981 | chr20:54435236:T:C | - | 0.0758480099484261 | 0.0241993232750626 | STAD | Male-baised eQTL |
| rs7271481 | chr20:54468453:C:T | - | 0.0706236216849045 | 0.0245571913454207 | STAD | Male-baised eQTL |
| rs7271579 | chr20:54468484:G:C | - | 0.0706236216849045 | 0.0245571913454207 | STAD | Male-baised eQTL |
| rs55665963 | chr20:54465336:T:G | - | 0.0705689574191076 | 0.0249579027585568 | STAD | Male-baised eQTL |
| rs6023248 | chr20:54441897:G:A | - | 0.0759345011266677 | 0.0258436643137139 | STAD | Male-baised eQTL |
| rs6014019 | chr20:54452526:A:G | - | 0.0746805538678226 | 0.0261095130340392 | STAD | Male-baised eQTL |
| rs113923922 | chr20:54604922:C:A | - | 0.0998228484905265 | 0.0261804633007293 | STAD | Male-baised eQTL |
| rs28503850 | chr20:54435826:A:G | - | 0.072464826186916 | 0.0273910919465497 | STAD | Male-baised eQTL |
| rs13433172 | chr20:54620332:G:A | - | 0.0902878353036931 | 0.0283097529960262 | STAD | Male-baised eQTL |
| rs34683517 | chr20:54489985:C:T | - | 0.072795951140987 | 0.0284240670117679 | STAD | Male-baised eQTL |
| rs6014016 | chr20:54439722:A:T | - | 0.0670694069587806 | 0.0296776621684672 | STAD | Male-baised eQTL |
| rs55880521 | chr20:54440290:G:T | - | 0.0670694069587806 | 0.0296776621684672 | STAD | Male-baised eQTL |
| rs6014017 | chr20:54440927:G:T | - | 0.0670694069587806 | 0.0296776621684672 | STAD | Male-baised eQTL |
| rs6023250 | chr20:54445166:C:T | - | 0.0670694069587806 | 0.0296776621684672 | STAD | Male-baised eQTL |
| rs6097986 | chr20:54445722:A:G | - | 0.0661285376707377 | 0.0297975058973497 | STAD | Male-baised eQTL |
| rs6098123 | chr20:54620494:C:T | - | 0.0897717294157965 | 0.0305617793163038 | STAD | Male-baised eQTL |
| rs6098011 | chr20:54480807:A:T | - | 0.0723637893676877 | 0.0311362169815616 | STAD | Male-baised eQTL |
| rs111918307 | chr20:54481281:T:G | - | 0.0723637893676877 | 0.0311362169815616 | STAD | Male-baised eQTL |
| rs11907067 | chr20:54430482:T:G | - | 0.0676231232328364 | 0.0328444562144167 | STAD | Male-baised eQTL |
| rs6023249 | chr20:54445074:T:C | - | 0.0646721513772371 | 0.0367778035180803 | STAD | Male-baised eQTL |
| rs16999610 | chr20:54431937:T:C | - | 0.0669579016065133 | 0.0376319949654673 | STAD | Male-baised eQTL |
| rs11904915 | chr20:54432999:A:G | - | 0.0669579016065133 | 0.0376319949654673 | STAD | Male-baised eQTL |
| rs6023258 | chr20:54454114:T:C | - | 0.0741029571723185 | 0.037910820835337 | STAD | Male-baised eQTL |
| rs6023432 | chr20:54631143:A:G | - | 0.0665215703779224 | 0.0441423401333601 | STAD | Male-baised eQTL |
| rs35321528 | chr20:54499539:T:C | - | 0.0692770343668228 | 0.0495028650640234 | STAD | Male-baised eQTL |
| rs6067080 | chr20:49401483:T:C | - | -0.0552019085471895 | 0.0289283161204718 | BLCA | Male-baised eQTL |
| rs3787316 | chr20:49400829:C:T | - | -0.0491877464793651 | 0.0452546827633314 | BLCA | Male-baised eQTL |
| rs6099621 | chr20:57435910:A:G | - | 0.0842576621339501 | 0.0464697782658557 | LUAD | Male-baised eQTL |
| rs1047920 | chr20:49988570:C:T | - | 0.0929754376710627 | 0.0219026782976272 | COAD | Male-baised eQTL |
| rs1891779 | chr20:61439719:T:C | - | -0.0611263305918326 | 0.0222927340335878 | COAD | Male-baised eQTL |
| rs6020996 | chr20:51129535:A:G | - | 0.0594193104272657 | 0.0304224738177636 | COAD | Male-baised eQTL |
| rs6067654 | chr20:51127012:C:T | - | 0.0577158284882624 | 0.0325688232929326 | COAD | Male-baised eQTL |
| rs6014415 | chr20:55555597:A:C | - | -0.0584664126216401 | 0.0360078037870547 | COAD | Male-baised eQTL |
| rs6020997 | chr20:51129788:A:G | - | 0.0581285723466095 | 0.0381185127129146 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000101166 |
| CpG Site: cg26216876 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.0497994064206354 | |
| Female Effect: - | |
 | Gene ID: ENSG00000101166 |
| CpG Site: cg06943251 | |
| Position to Gene: gene | |
| Male Effect: -0.269473890432788 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg26216876 | chr20:59042028 | gene,promoter | -0.0497994064206354 | 7.11935541232397e-05 | -0.33150672046701546 | 5.816165464999456e-07 | LUAD |
| cg06943251 | chr20:59040343 | gene | -0.269473890432788 | 1.04030299263563e-16 | -0.5544554876623332 | 4.741466211927324e-19 | STAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of SLMO2 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
